We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
What helps and what hinders in remotely delivered acceptance and commitment therapy for survivors of childhood brain tumours: a diary and interview study.
An open label, single centre, single arm, prospective feasibility study evaluating the effectiveness of near-infrared fluorescence(NIRF)using indo-cyanine green(ICG)in intra-abdominal or intra-thoracic minimally invasive surgery(MIS)in paediatric oncology.
Living with treatment-related hearing loss: Experiences of survivors of childhood brain cancer
Towards chemotherapy-free treatment of paediatric post-transplant lymphoproliferative disorders
Identifying drivers of central nervous system involvement in T-cell acute lymphoblastic leukaemia
Investigating the preclinical efficacy of albendazole in paediatric acute myeloid leukaemia
Dissecting the role of CD133/PROM1 in MLL rearranged acute lymphoblastic leukaemia to develop novel targeted therapy
The Role of Cut-and-Run, an Aberrant V(D)J Recombination Reaction, in the Development of Acute Lymphoblastic Leukaemias with Poor Prognosis
Towards a new therapy against childhood brain cancer: How does the Zika virus kill aggressive brain tumour cells?
